Resultados de la búsqueda 11-20 of 2878 for ������������KA���:ZA31���24������ ���������������������������������

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  3. Chemotherapy for colon cancer - Mayo Clinic

    Chemotherapy is often used to treat colon cancer. Find out how to prepare for your treatment and how to handle possible side effects.

  4. Mayo Clinic Physician Update - December 2024

    Page 1.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  9. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia - Mayo Clinic

    Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia · Tu donación es muy poderosa... ¿quieres ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...